ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Company Led - DRUG ALERT - LYSAKARE 25 G / 25 G SOLUTION FOR INFUSION

Recalls and Alerts

Company-led Recall

Company Led - DRUG ALERT - LYSAKARE 25 G / 25 G SOLUTION FOR INFUSION

Advanced Accelerator Applications Ltd is recalling the below batch of LysaKare 25 g / 25 g solution for infusion (PLGB 35145/0005) as it was identified during the inspection process by the manufacturer that a small number of bags were observed to be leaking..”

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/company-led-medicines-recall-lysakare-25-g-slash-25-g-solution-for-infusion-plgb-35145-slash-0005?utm_medium=email&utm_campaign=govuk-notifications&utm_source=125027c5-2625-4ae7-a249-7c9dc4b72260&utm_content=immediately   

Pip code

Product description

Supplier

Batch numbers

Alliance do not stock

LYSAKARE 25 G / 25 G SOLUTION FOR INFUSION

ADVANCED ACCELERATOR APPLICATIONS (UK & IRELAND) LTD

210155

 

Alliance do not stock this product and therefore we are not accepting stock returns.

 

Company contact for medical information enquiries

For medical information enquiries, please contact: Advanced Accelerator Applications (UK & Ireland) Ltd infomed@adacap.com.

 

Company contact for stock enquiries

For stock information enquiries contact Advanced Accelerator Applications (UK & Ireland) Ltd by emailing: customersvc.aaauk@novartis.com, tel. +44(0)20 72585200

 

If you have any questions, then please contact your local Service Centre Customer Services team.